How many mutant p53 molecules are needed to inactivate a tetramer?

WM Chan, WY Siu, A Lau, RYC Poon - Molecular and cellular …, 2004 - Taylor & Francis
WM Chan, WY Siu, A Lau, RYC Poon
Molecular and cellular biology, 2004Taylor & Francis
The tumor suppressor p53 is transcription factor composed of four identical subunits. The
majority of the mutations in p53 are missense mutations that impair DNA binding. On the
other hand, the p53-related p63 and p73 genes are rarely mutated, but many cell types
express natural variants lacking the N-terminal transactivation domain (NΔ). Compelling
evidence indicates that both the DNA binding-defective and NΔ mutants can impair the
function of wild-type p53 in a dominant-negative manner. Interestingly, it is uncertain how …
The tumor suppressor p53 is transcription factor composed of four identical subunits. The majority of the mutations in p53 are missense mutations that impair DNA binding. On the other hand, the p53-related p63 and p73 genes are rarely mutated, but many cell types express natural variants lacking the N-terminal transactivation domain (NΔ). Compelling evidence indicates that both the DNA binding-defective and NΔ mutants can impair the function of wild-type p53 in a dominant-negative manner. Interestingly, it is uncertain how many mutant subunit(s) a p53 tetramer can tolerate. In this study, we first made theoretical predictions based on the number of mutant p53 monomers needed to inactivate a tetramer and then tested how well the experimental data fit the predicted values. Surprisingly, these experiments reveal that DNA binding-defective p53 mutants (R249S and R273H) are very ineffective in impairing the transcriptional activity of p53: at least three mutants are required to inactivate a tetramer. In marked contrast, p53NΔ is a very potent inhibitor of p53: one NΔ subunit per tetramer is sufficient to abolish the transcriptional activity. DNA binding is not necessary for the NΔ proteins to inactivate p53. Similarly, NΔ variants of p63 and p73 are also powerful inhibitors of members of the p53 family. These results have important implications for our thinking about the mechanism of tumorigenesis involving missense p53 mutants or the N-terminally truncated isoforms.
Taylor & Francis Online